ALPHASUITEATLASTM

PDB 9R2Q

p53 bound to nucleosome at position SHL-5.7 (non-crosslinked sample)

ELECTRON MICROSCOPY · 3.2 Å

Open in Atlas →Interactive 3D viewing requires a desktop browser.

Protein descriptions

Descriptions refer to the mapped proteins, not necessarily the full deposited construct or assembly.

P04637 · Chains K, L, M, N

Cellular tumor antigen p53

Homo sapiens

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence [1–17]. Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type [1, 2, 3, 4, 5, 18, 6, 7, 8, 9, 10, 11, 12, 13, 16, 17]. Negatively regulates cell division by controlling expression of a set of genes required for this process [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 17].

One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression [2, 18]. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 [2].

However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP [2]. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1.

LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression.

Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis.

Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 [12]

UniProt · P04637 · Snapshot 10/11/2026

Supporting publications · 18
  1. PubMed 11025664
  2. PubMed 12524540
  3. PubMed 12810724
  4. PubMed 15186775
  5. PubMed 15340061
  6. PubMed 17317671
  7. PubMed 17349958
  8. PubMed 19556538
  9. PubMed 20673990
  10. PubMed 20959462
  11. PubMed 22726440
  12. PubMed 24051492
  13. PubMed 24652652
  14. PubMed 35618207
  15. PubMed 36634798
  16. PubMed 38653238
  17. PubMed 9840937
  18. PubMed 17189187

Components and protein mappings

Mappings below identify source-linked proteins. They do not establish residue-level annotation coverage or direct binding.

  • Histone H3.1

    PROTEIN · Chains A, E

    Homo sapiens

    P68431

  • Histone H4

    PROTEIN · Chains B, F

    Homo sapiens

    P62805

  • Histone H2A type 1-B/E

    PROTEIN · Chains C, G

    Homo sapiens

    P04908

  • Histone H2B type 1-J

    PROTEIN · Chains D, H

    Homo sapiens

    P06899

  • DNA-for

    DNA · Chains I

    synthetic construct

    No UniProt mapping provided

  • DNA-rev

    DNA · Chains J

    synthetic construct

    No UniProt mapping provided

  • Cellular tumor antigen p53

    PROTEIN · Chains K, L, M, N

    Homo sapiens

    P04637

Protein annotations are displayed in the viewer only where residue mappings are verified. Domain annotations do not apply to DNA or RNA.

Biological assemblies

  • Assembly 1

    author and software defined assembly

    Component membership checked · Chains A, B, C, D, E, F, G, H, I, J, K, L, M, N

    Open assembly 1 →

Primary publication

p53 bound to nucleosome at position SHL-5.7 (non-crosslinked sample)

Paper date: not available

Sources and attribution

Snapshot updated 09/11/2026. Source descriptions are attributed below; Atlas combines and displays their annotations.

No provider endorsement is implied. Attribution and reuse terms.